腹膜透性与腹透症在腹透析患者之间的关系
Gonca Tanırlı Kayakıran1, Sumeyra Koyuncu2,3, Ismail Kocyigit4
1Department of Internal Medicine, Erciyes Medical Faculty, Kayseri, Turkey.
International urology and nephrology
|May 23, 2024
概括
腹腔透析患者中常见的消化不良,特别是那些膜透度低的患者. 这种情况往往是功能性的,更严重,在低透率组中更频繁.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
- 临床医学 临床医学
背景情况:
- 消化不良影响了接受腹腔透析的大量患者.
- 了解这些人群中导致消化不良的因素对于改善患者护理至关重要.
研究的目的:
- 研究腹膜透性和腹透症的流行率和严重程度在腹透析患者之间的关系.
主要方法:
- 一组95名腹腔透析患者的队列使用ROME-IV标准和格拉斯哥腹严重程度评分来评估腹不良.
- 腹膜平衡试验 (PET) 的值被用来将患者分为低透性和高透性组.
- 进行了H. pylori检测和内镜检查,以排除腹的有机原因.
主要成果:
- 消化不良症在51.6%的患者中存在.
- 腹膜透性较低的患者表现出更高的腹的频率和严重程度.
- 在透性小组之间没有观察到H. pylori发生的显著差异,而低透性小组的消化不良主要是功能性的.
结论:
- 腹是腹透析患者中普遍存在的问题,经常与腹膜透率低有关.
- 功能性质和低透性患者消化不良的严重程度增加需要在透析规划时考虑.
- 临床管理应包括患者教育和针对低透性的患者采取量身定制的预防措施.
相关概念视频
Peptic Ulcer Disease II: Pathophysiology
390
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
390
Peptic Ulcer Disease I: Introduction
163
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
163
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
111
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
111
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
570
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
570
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
380
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
380
Dialysis
641
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
641


